The data presented are from experiments in primary microglia isolated from young and aged mice treated with Aβ in vitro, immortalized IMG cells treated with a DMT1 inhibitor followed by Aβ and iron, and data from a triple-transgenic AD mouse model with microglial Slc11a2 knockdown in both sexes. The gene discussed is SLC11A2; the disease is Alzheimer disease.